Dynavox Group is a global supplier of assistive communication devices and solutions for individuals with communication impairments. The company operates through its primary subsidiary, Tobii Dynavox, offering a comprehensive ecosystem of hardware, software, and services. Its product portfolio includes eye-gaze controlled communication solutions with integrated eye-tracking sensors, touch-screen controlled devices, and AI-based speech synthesis software that provides personalized voice identities in over 30 languages. These Augmentative and Alternative Communication (AAC) solutions are designed for users with conditions such as cerebral palsy, ALS, autism, and spinal cord injury. Dynavox Group serves a global market with a direct presence in multiple countries, with its main markets concentrated in regions with established reimbursement and prescription systems. The company’s customer base includes prescribers, end-users, and public or private payers such as insurance companies and healthcare institutions. Recent strategic acquisitions include RehaMedia in Germany, Cenomy in France, and SR Labs Healthcare in Italy, which have established direct market presence in these regions. The company also maintains a long-term supply agreement with Tobii AB for eye-tracking components. Dynavox Group was formerly known as Tobii Dynavox before changing its listed entity name in 2024, and its history traces back to the 1991 launch of the first touch-screen communication aid by DynaVox Systems and the 2001 development of the first eye-tracking technology by Tobii Technology.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Medical Devices Homepage dynavoxgroup.com
Sector Healthcare IR page dynavoxgroup.com
Tags
assistive communication, augmentative and alternative communication, eye-tracking, speech synthesis, disability technology, rehabilitation technology, accessibility solutions, medical devices, Tobii Dynavox, Tobii Technology, DynaVox Systems, RehaMedia, Cenomy, SR Labs Healthcare, Tobii AB
Press page —

Metrics

Valuation  
Market cap kr 8.199B
Market cap (USD) $ 810.955M
P/E 49.48
PEG 0.98
P/BV 12.24
P/S 3.32
P/OCF 41.70
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 31.4%
ROI 11.1%
ROIC 13.6%
Profit margin 6.7%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 50.5%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 148.8%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 27
Quality score 23.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 2.467B 1.972B 1.613B 1.216B 871.6M 895.2M
Net profit 165.7M 145.8M 104.1M 48.6M 29.8M 129.8M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 130.1 55.3 29.01 23.2 32.66 —
Price performance 12m 1.35 0.91 0.25 -0.29 — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 125M 139M 237M 270M 388M 414M
↳ YoY growth +11.7% +70.2% +14.0% +43.7% +6.8%
↳ 5y CAGR +27.2%
Other receivables (SEK) — 14.6M 30.2M 23.1M 33.3M 39.2M 64.4M
Borrowings, current (SEK) — 363M 0.00 48.8M 58.8M 44M 67.5M
Borrowings, non-current (SEK) — 0.00 548M 521M 616M 648M 829M
Lease liabilities (SEK) — 53.2M 59M 58.7M 98.1M 99.3M 207M
Cash and deposits (SEK) 48.6M 173M 197M 107M 161M 134M 195M
Intangible assets (SEK) — 277M 573M 674M — — —
Right-of-use assets (SEK) — 51.5M 52.4M 50.4M 91M 91.6M 179M
Net debt (borrowings + leases - cash) (SEK) — 243M 409M 522M 612M 657M 909M
Cash flow detail
Operating cash flow (SEK) — 273M 137M 96.2M 277M 283M 197M
Purchases of property, plant and equipment (SEK) — -23.6M -10.8M -31.5M -45.5M -61.6M -93.3M
Purchases of intangible assets (SEK) — -78.4M -357M -86.7M -89M -122M -112M
Change in receivables (cash effect) (SEK) — 8.8M -20.5M -51.9M -45.4M -105M -111M
Change in inventories (cash effect) (SEK) — 19.1M -14.7M -20.2M -21.9M -61.3M -154M
Change in payables (cash effect) (SEK) — 34.9M 35.5M -11M 76.5M 95.1M 46.7M
Share buybacks (cash effect) (SEK) — — — -1M -3.6M -28.3M —
Income taxes paid (cash effect) (SEK) — -1.5M -3.1M -6.2M -12.7M -32.7M -51.2M
Operating cash flow before change in receivables (SEK) — 264M 157M 148M 323M 387M 308M
Free cash flow (OCF - PPE - intangibles) (SEK) — 171M -231M -22M 143M 99.4M -8.3M
Income detail
Research and development expense (SEK) — 109M 117M 138M 164M 184M 245M
↳ 5y CAGR +17.7%
Total comprehensive income (SEK) — 126M 35.8M 67.4M 82.2M 171M 104M
Comprehensive income to owners (SEK) — 126M 35.8M 67.4M 82.2M 171M 104M
Reported — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Dynavox Group Interim Report third quarter 2026 Bull 5 Bear 0 Results

Continued solid growth and significantly strengthened profitability

“Dynavox Group continued to deliver solid growth and significantly strengthened profitability in the third quarter, despite demanding reimbursement processes in the United States. Revenue growth was broad-based, with currency adjusted growth of 15%, while the EBIT margin reached 17.4%. Once again, we demonstrate the resilience of our business, supported by strong underlying demand and disciplined execution.”

Fredrik Ruben, CEO Dynavox Group

QUARTER JULY – SEPTEMBER 2026

  • Currency adjusted revenue growth was 15%. Reported revenue increased 13% to SEK 685 million (606).

  • Gross margin was 69% (70).

  • Currency adjusted EBIT growth was 94%. Reported operating profit increased by 87% to SEK 119 million (64), corresponding to an operating margin of 17.4% (10.6).

  • Cash flow after continuous investments increased by 213% to SEK 62 million (20).

  • Basic earnings per share increased by 134% to SEK 0.83 (0.36) before dilution and SEK 0.83 (0.35) after dilution.

PERIOD JANUARY – SEPTEMBER 2026

  • Currency adjusted revenue growth was 15%. Reported revenue increased 9% to SEK 1,942 million (1,790). 

  • Gross margin was 69% (68).

  • Currency adjusted EBIT growth was 98%. Reported operating profit increased by 87% to SEK 282 million (151), corresponding to an operating margin of 14.5% (8.4).

  • Cash flow after continuous investments increased by 441% to SEK 184 million (-54).

  • Basic earnings per share increased by 121% to SEK 1.89 (0.86) before dilution and SEK 1.87 (0.85) after dilution.

SIGNIFICANT EVENTS DURING THE QUARTER

as Chief Financial Officer (CFO) and a member of the Executive Management Team in September.

COMMENTS FROM THE CEO:

Dynavox Group continued to deliver solid growth and significantly strengthened profitability in the third quarter, despite demanding reimbursement processes in the United States. Revenue growth was broad-based, with currency adjusted growth of 15%, while the EBIT margin reached 17.4%. Once again, we demonstrate the resilience of our business, supported by strong underlying demand and disciplined execution.

The underlying market demand remains strong, and the long-term growth opportunity is unchanged. In the U.S., however, increased administrative complexity and longer lead times, primarily related to Medicaid and Medicaid managed care organizations, held back growth. Specific reimbursement challenges in two major states were resolved in our favor during the quarter, but state-by-state complexity is expected to remain a headwind. These challenges are not new, but the number of cases requiring additional review, and the effort needed to resolve them, has increased amid broader pressure on public spending.

In Europe and other markets, the performance was more mixed, with Germany and Australia as the strongest contributors to growth. Germany continues to be particularly promising as we mark the first year of operating as one integrated organization after the acquisition of RehaMedia. Across the entire market, we are strengthening local execution, building on the businesses we have acquired and creating a more scalable platform for continued growth.

We continue to challenge market practices that, in our view, risk creating confusion around product delivery, support, reimbursement and intellectual property. Our legal action against AbleNet, filed in May this year, is intended to protect patients, prescribing professionals and the integrity of established delivery standards for assistive communication solutions. We will continue to pursue this matter responsibly while remaining focused on serving our customers.

Gross margin remained strong despite higher component costs, supported in part by more efficient operations and improved logistics. Cost control also remained well balanced overall. We continue to invest in digitalization, systems and organizational capabilities, while significant one-off costs associated with building our operating platform are now largely behind us.

Our organization has grown significantly over the past few years, both organically and through acquisitions. Aligning how we work across this larger team is therefore as important an investment in our future as the implementation of our new ERP platform, new digital tools and modern distribution centers. This will be a key focus as we enter 2027. We now believe the foundational pieces are in place for the next chapter of our growth journey.

We are confident in the long-term fundamentals of serving and improving an underserved market, coupled with our ability to generate sustainable, profitable growth. Our priorities are to improve market access, strengthen commercial execution and capture further operating leverage as we scale. I expect that we will have periods of headwinds and challenges as well as continued significant growth and momentum along this journey. In December this year we celebrate the fifth anniversary of the public listing of Dynavox Group as a stand-alone company and can look back at five years of 25 % average annual revenue growth while building a stronger, more professional and financially solid company – and I am as confident as ever before that we have barely started.

Fredrik Ruben, CEO

Webcast:

Today at 9:00 a.m. CEST, Dynavox Group will host a webcast presentation for media, analysts and investors. If you want to attend the webcast click the following link

. The report and a recording of the webcast will be availablehere

after the webcast.

Dynavox Group AB (publ) today announced the company's Nomination Committee for the Annual General Meeting 2027. 

In accordance with the principles adopted by the Annual General Meeting 2026, the Nomination Committee for the 2027 Annual General Meeting has been established. The Nomination Committee consists of the following members:

  • Gustaf Runius, appointed by SEB Funds AB

  • Alexander Togba, appointed by Ferd AS

  • Joachim Spetz, appointed by Swedbank Robur Fonder

  • Gitte Pugholm Aabo, Chair of the Board of Directors (co-opted member)

Gustaf Runius has been appointed Chair of the Nomination Committee.

Dynavox Group will publish the interim report for the third quarter 2026 on October 21 at 07.30 a.m. CET. Following the report, at 09.00 a.m. CET, Dynavox Group will host a webcast for investors, analysts and media.  

The presentation will be hosted by CEO Fredrik Ruben, and CFO Jacob Thordenberg, followed by questions and answers. Questions can be submitted in the Q&A function or verbally by raising the hand in Teams during the event. Presentation materials and a recording will be available on Dynavox Group’swebsite

after the event.

Webcast details:

Time**: October 21, 2026 at 09.00 am CET**

Join**:**Link to webcast

Q&A: Please use the Q&A function in Teams or raise your hand to ask questions verbally, with or without camera.

Invitation to Dynavox Group's webcast following the interim report for the third quarter 2026

Prompts

Dynavox Group (ticker DYVOX), listed in Sweden.

ETFs Holding Dynavox Group

ETF Weight in ETF Shares Market value As of
AVDV 0.08% 2,293,653 $ 16.407M Nov 16, 2026
DFIS 0.03% 242,052 $ 1.783M Nov 12, 2026
AVDS 0.03% 17,662 $ 126.342K Nov 16, 2026
AVSD 0.01% 6,202 $ 44.365K Nov 16, 2026
DFIC 0.01% 148,155 $ 1.092M Nov 12, 2026
DFSI 0.01% 9,727 $ 71.662K Nov 12, 2026
DFAX 0.00% 52,770 $ 388.774K Nov 12, 2026
DFAI 0.00% 74,508 $ 548.926K Nov 12, 2026
AVDE 0.00% 134,752 $ 963.923K Nov 16, 2026